226Ra irradiation to produce 225Ac and 213Bi in an accelerator-driven system reactor

被引:9
|
作者
Al Qaaod, Amer A. [1 ]
Gulik, Volodymyr [2 ]
机构
[1] Abdus Salaam Int Ctr Theoret Phys, Trieste, Italy
[2] Inst Safety Problems NPPs, Kiev, Ukraine
关键词
Th-229; production; Ra-226; irradiation; Targeted alpha therapy; ADS reactor; Monte Carlo; NONUNIFORM DISTRIBUTIONS; ADS; TRANSMUTATION; GENERATION; UNIFORM; MYRRHA;
D O I
10.1007/s41365-020-00753-2
中图分类号
TL [原子能技术]; O571 [原子核物理学];
学科分类号
0827 ; 082701 ;
摘要
This study aims to produce Th-229 using an innovative nuclear reactor concept, i.e., accelerator-driven system (ADS) reactor. Herein, we investigated the feasibility of producing Th-229 from neutron transmutation of Ra-226 to expand the availability of Ac-225 and Bi-213 in a simple model of ADS reactor. ADS reactor comprises two zones, i.e., an inner zone with a fast neutron spectrum and outer zone with thermal neutron spectrum, which is a subcritical core coupled with an external neutron source. Transmutation behavior, activity, and mass ratio of the obtained isotopes were investigated using the Monte-Carlo tool. In addition with offering the capability, flexibility, and safety of radioactive waste transmutation, the proposed ADS model provides high Th-229 yield and requires less time than a critical reactor with the same neutron flux and irradiated quantity of Ra-226.
引用
收藏
页数:6
相关论文
共 44 条
  • [21] Cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production
    Lebeda, Ondrej
    Fialova, Katerina Ondrak
    Ondrak, Lukas
    Cervenak, Jaroslav
    Ralis, Jan
    Stursa, Jan
    NUCLEAR MEDICINE AND BIOLOGY, 2025, 142
  • [22] Improved method for labelling DOTA-analogues with 213Bi, 225Ac and lanthanides.
    Nikula, TK
    Apostolidis, C
    Carlos-Marquez, R
    Jehenson, P
    Mäcke, H
    Martin, S
    Ouadi, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U259 - U259
  • [23] Gas-chemical approach to 225Ac/213Bi radionuclide generator for medical application
    Zobnin, Vladislav A.
    Zhuikov, Boris L.
    Vasiliev, Aleksandr N.
    Polnyakov, Gleb A.
    APPLIED RADIATION AND ISOTOPES, 2025, 215
  • [24] Production of high-purity α-emitting 225Ac and 213Bi radionuclides for use in nuclear medicine
    Guseva L.I.
    Radiochemistry, 2013, 55 (3) : 317 - 323
  • [25] Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator:: development of new methods, quantitative characterization, and implications for clinical use
    Ma, DH
    McDevitt, MR
    Finn, RD
    Scheinberg, DA
    APPLIED RADIATION AND ISOTOPES, 2001, 55 (05) : 667 - 678
  • [26] Status of the 226Ra nuclear data library and its impact on the production amount of 225Ac via the 226Ra (n,2n) reaction
    Sasaki, Yuto
    Iwamoto, Nobuyuki
    Takaki, Naoyuki
    Maeda, Shigetaka
    JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, 2024, 61 (02) : 251 - 260
  • [27] An electrochemical generator for the continual supply of 213Bi from 225Ac for use in targeted alpha therapy applications
    Forrester, Ryan
    Dutech, Guy
    Akin, Andrew
    Fassbender, Michael E.
    Mastren, Tara
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 136
  • [28] Pharmacokinetic variability 225Ac and 213Bi from vector labeled 225Ac cancer therapy as a function of vector type (antibody vs. small molecule)
    Josefsson, Anders
    Nedrow, Jessie
    Ray, Sangeeta
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Pomper, Martin
    Sgouros, George
    Hobbs, Robert
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [29] Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac]Ac-DOTATATE in preclinical model
    Liu Dijie
    Li, Mengshi
    Dai, Zhiming
    Cagle, Brianna
    Lee, Dongyoul
    Schultz, Michael
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S265 - S266
  • [30] Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y
    Song, Hong
    Hobbs, Robert F.
    Vajravelu, Ravy
    Huso, David L.
    Esaias, Caroline
    Apostolidis, Christos
    Morgenstern, Alfred
    Sgouros, George
    CANCER RESEARCH, 2009, 69 (23) : 8941 - 8948